HomeNDC LookupIngredientsMiconazole Nitrate › 70000-0679-01
Antifungal Powder Miconazole Nitrate 20 mg/g Powder, 71 g — NDC 70000-0679-01 package photo

Antifungal Powder Miconazole Nitrate 20 mg/g Powder, 71 g

by LEADER/ Cardinal Health 110, Inc. · 71 g in 1 BOTTLE, PLASTIC (70000-0679-1)
NDC 70000-0679-01
🏷️ FDA NDC (as labeled) 70000-0679-1 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Miconazole Nitrate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 10, 2024 — Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0315-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 70000-0679-1
Product NDC 70000-0679
11-digit billing NDC 70000067901
NCPDP billing unit GM — per gram (weight)
RxCUI 998461
UNII VW4H1CYW1K
UPC 0096295143508
Application # M005
SPL Set ID 1fcf072b-cf12-967a-e063-6294a90acfc7
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-08-16
Route TOPICAL
Dosage form POWDER
Substance MICONAZOLE NITRATE
GPI-14 90154050102910
GCN Seq No 007367
GCN 30410
HICL code 003031
Ingredient (HICL) Miconazole Nitrate
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 84:04.08.08
AHFS class Azoles (Skin And Mucous Membrane)
FDB label name ANTIFUNGAL 2% POWDER
FDB brand name Antifungal Powder
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 70000-0679-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0679-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Imidazole derivatives, Imidazole and triazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerLEADER/ Cardinal Health 110, Inc.
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedAug 2024
Product typeHuman Otc Drug
Portfolio38 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name ANTIFUNGAL 2% POWDER Ingredient Miconazole Nitrate
📖 What it is MedlinePlus · NLM

Topical miconazole is used to treat tinea corporis(ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), and tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes). Miconazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection. Not all products should be used to treat all of these conditions. Please read the label for each product to select the one to treat your conditi...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • For a 7-night vaginal cream, you insert one full applicator into your vagina at bedtime for 7 nights in a row. If you have itching or irritation on the outside, squeeze a small amo...
  • I bought a miconazole cream for a vaginal yeast infection — how do I use it correctly?
  • Yes — topical miconazole creams and powders are specifically made for those conditions. For athlete's foot and ringworm, you'd apply it to clean, dry skin twice a day for 4 weeks....
  • Can I use miconazole cream on my skin for athlete's foot or jock itch?
📖 Read our full Miconazole guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 344S277G0Z
    Allantoin is a naturally derived compound that helps soften and soothe skin. In medicines, it works as a skin-conditioning agent and may help support wound healing and reduce irritation in topical formulations.
  • UNII 0F32U78V2Q
    Chloroxylenol is a synthetic antimicrobial chemical used as a preservative in medicines and personal care products. It prevents bacterial and fungal growth to help keep the medication safe and effective during storage.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 8MDF5V39QO
    A white powder form of baking soda that acts as a buffer and pH regulator in medicines. It helps maintain the right acid-base balance and may aid tablet disintegration.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII K4C08XP666
    A mineral salt made from calcium and phosphate. It acts as a filler to add bulk and texture to tablets and powders, and also helps stabilize and bind ingredients together.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesZea Mays (Corn) Starch, Tricalcium Phosphate, Microcrystalline Cellulose, Sodium Bicarbonate, Allantoin, Chloroxylenol, Fragrance

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.058 $4.11 / 71 g
Medicaid paysCMS SDUD · 12 mo $0.1296 $9.20 / 71 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2025 Feb 2026 May 2026 Aug 2026 $0.058 $0.056
▲ Up 3% over the last 9 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Miconazorb AF 20 mg/g 46122-0789-29 AmerisourceBergen 71 g $0.058 Availability likely
Miconazole Nitrate 1.42 g/71g 70000-0323-01 LEADER/ 71 g $0.058 Availability likely
Antifungal Powder 20 mg/gthis 70000-0679-01 LEADER/ 71 g $0.058 Availability likely
Desenex 20 mg/g 00316-0225-15 Crown 43 g Discontinued
Zeasorb Athletes Foot 20 mg/g 00316-8000-01 Crown 71 g FDA listed
Zeasorb Jock Itch 20 mg/g 00316-8001-02 Crown 71 g FDA listed
Foot Powder 20 mg/g 00363-7999-01 Walgreens 71 g FDA listed
Jock Itch Powder 20 mg/g 00363-9223-01 Walgreens 71 g FDA listed
Miconazole Nitrate Antifungal Powder 2 g/100g 10135-0720-85 Marlex 85 g FDA listed
Lotrimin AF Jock Itch 20 mg/g 11523-0150-01 Bayer 177 g FDA listed
Lotrimin Antifungal 20 mg/g 11523-0919-01 Bayer 90 g FDA listed
Micro-Guard (AF) 20 mg/g 11701-0038-16 Coloplast 85 g FDA listed
Anti-Fungal Powder 20 mg/g 30142-0947-71 The 71 g FDA listed
Miconazole Nitrate 1.42 g/71g 36800-0385-25 Topco 71 g FDA listed
Anti-Fungal Powder 20 mg/g 36800-0613-01 TopCo 71 g FDA listed
Miconazole Nitrate 2 g/100g 42291-0938-85 AvKARE 85 g FDA listed
Anti-Fungal Powder 20 mg/g 51316-0980-01 CVS 71 g FDA listed
Remedy Antifungal 2 g/100g 53329-0169-79 Medline 85 g FDA listed
Miconazole Nitrate 20 mg/g 53943-0976-01 Discount 71 g FDA listed
ProCure Antifungal 2 g/100g 55681-0043-03 Twin 85 g FDA listed
Anti- Fungal Miconazole Nitrate 1.42 g/71g 56104-0253-01 Premier 71 g FDA listed
Anti-fungal Powder Miconazole Nitrate 20 mg/g 56104-0500-00 Premier 71 g FDA listed
Medicated Athletes Foot Powder 20 mg/g 56104-0906-01 Premier 99 g FDA listed
Mycozyl AP 2 g/85g 59088-0442-07 PureTek 85 g FDA listed
Micotrin AP 2 g/85g 59088-0478-07 PureTek 85 g FDA listed
1236-CS Antifungal Powder (Talc Free) 20 mg/g 67777-0313-04 Dynarex 24 bottles FDA listed
THERA Antifungal Body 20 mg/g 68599-0207-03 McKesson 85 g FDA listed
GeriGentle Miconazole nitrate 2 g/100g 69771-0165-03 GERI-GENTLE 85 g FDA listed
Miconazole Nitrate 1.42 g/71g 69842-0490-25 CVS 71 g FDA listed
Miconazole Nitrate 1.42 g/71g 72446-0007-71 Hudson 71 g FDA listed
Miconazole Nitrate 20 mg/g 72446-0014-01 Hudson 71 g FDA listed
DCH Labs Antifungal Jock 2 g/100g 72839-0096-02 Derma 71 g FDA listed
Warrior Antifungal Foot 2 g/100g 72839-0961-02 Derma 71 g FDA listed
Anti-fungal Powder Miconazole Nitrate 20 mg/g 79481-0621-01 Meijer 71 g FDA listed
Antifungal 20 mg/g 80513-0771-03 Advanced 85 g FDA listed
Evercare Antifungal Treatment Super Absorbent Powder 20 mg/g 83099-0000-00 PANEFFORT, 85 g FDA listed
Dermachange Jock 2 g/100g 83520-0961-02 Private 71 g FDA listed
Happy Nuts Jock Itch Powder 2 g/100g 87151-0111-01 Suit 71 g FDA listed
Antifungal Powder 2 g/100g 87236-0012-03 Aldermed 85 g FDA listed
Jock Itch Powder 20 mg/g 56104-0122-01 Premier 127 g FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Aug 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70000-0679-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.2K
Units reimbursed last 4 qtrs
83.1K
Gross reimbursed last 4 qtrs
$10.8K
Avg / prescription
$9.29
Avg / unit
$0.1296
Latest quarter Q4 2025
575Rx
Medicaid pays / g
$0.1296
gross reimbursed
vs
NADAC / g
$0.0579
acquisition cost
=
Spread
+$0.0717
+124% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
29% FFS 71% MCO
Fee-for-service · 340 Rx Managed care · 820 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 9,204 units · 160 per 100k residents MN Wisconsin: 11,573 units · 196 per 100k residents WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 3,280 units · 77.5 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 4,970 units · 72.4 per 100k residents IN Ohio: 11,138 units · 94.5 per 100k residents OH Pennsylvania: 11,973 units · 92.4 per 100k residents PA New Jersey: 4,856 units · 52.3 per 100k residents NJ Massachusetts: 2,144 units · 30.6 per 100k residents MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 15,222 units · 770 per 100k residents NE Missouri: no data reported MO Kentucky: 6 units · 0.1 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: 3,692 units · 102 per 100k residents CT Rhode Island: no data reported RI Arizona: 852 units · 11.5 per 100k residents AZ New Mexico: no data reported NM Kansas: 4,203 units · 143 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
0.1770
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Nebraska 770 /100k
2 Wisconsin 196 /100k
3 Minnesota 160 /100k
4 Kansas 143 /100k
5 Connecticut 102 /100k
6 Ohio 94.5 /100k
7 Pennsylvania 92.4 /100k
8 Oregon 77.5 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Miconazole 3 (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Miconazole 3. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$35.6K
Claims incl. refills
725
Beneficiaries
649
Spend / beneficiary
$54.91
Spend / claim
$49.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Miconazole Nitrate — the ingredient across all brands.

Top reported reactions

Vulvovaginal Burning Sensation1,864
Vulvovaginal Pain1,001
Vulvovaginal Pruritus616
Condition Aggravated570
Vaginal Haemorrhage482
Vulvovaginal Discomfort460
Vulvovaginal Swelling317

Age at onset

Neonate8
Infant6
Child15
Adolescent12
Adult526
Elderly274

Reporter sex

8,750 reports
Male · 18%
Female · 81%
Unknown · 0%

Serious outcomes

Hospitalization1,647
Death433
Life-threatening293
Disabling188
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 734 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
70000-0679-01 You're viewing this 71 g in 1 BOTTLE, PLASTIC (70000-0679-1) 2024-08-16 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 15 words

Uses for the cure of most athlete's foot, ringworm and chafing associated with jock itch

⏱️ Dosage and Administration 96 words

Directions clean the affected area and dry thoroughly apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, & change shoes & socks at least once daily for athlete's foot & ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks if conditions persist longer, consult a doctor this product is not effective on the scalp or nails

⚠️ Warnings 75 words

Warnings For external use only. Do not use on children under 2 years of age unless directed by a doctor. When using this product avoid contact with the eyes Stop and ask a doctor if irritation occurs or there is no improvement within 4 weeks for athlete's foot and ringworm, or 2 weeks for jock itch. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words

Active ingredient Miconazole nitrate 2%

🧪 Inactive Ingredients 15 words

Inactive ingredients Zea Mays (Corn) Starch, Tricalcium Phosphate, Microcrystalline Cellulose, Sodium Bicarbonate, Allantoin, Chloroxylenol, Fragrance

🎯 Purpose 2 words

Purpose Antifungal

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.